These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11245967)

  • 41. Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: evidence from pharmacological analysis.
    Idova GV; Alperina EL; Cheido MA
    Int Immunopharmacol; 2012 Apr; 12(4):618-25. PubMed ID: 22406177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A monoclonal anti-idiotypic antibody to mu and delta opioid receptors.
    Coscia CJ; Szücs M; Barg J; Belcheva MM; Bem WT; Khoobehi K; Donnigan TA; Juszczak R; McHale RJ; Hanley MR
    Brain Res Mol Brain Res; 1991 Mar; 9(4):299-306. PubMed ID: 1645433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cloning of opioid receptors in common carp (Cyprinus carpio L.) and their involvement in regulation of stress and immune response.
    Chadzinska M; Hermsen T; Savelkoul HF; Verburg-van Kemenade BM
    Brain Behav Immun; 2009 Feb; 23(2):257-66. PubMed ID: 18977430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids.
    Tseng RJ; Padgett DA; Dhabhar FS; Engler H; Sheridan JF
    Brain Behav Immun; 2005 Mar; 19(2):153-64. PubMed ID: 15664788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of opioids on phagocytic function, oxidative burst capacity, cytokine production and apoptosis in canine leukocytes.
    Declue AE; Yu DH; Prochnow S; Axiak-Bechtel S; Amorim J; Tsuruta K; Donaldson R; Lino G; Monibi F; Honaker A; Dodam J
    Vet J; 2014 May; 200(2):270-5. PubMed ID: 24679456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioids and pain.
    Kanjhan R
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):397-403. PubMed ID: 8582088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.
    Nelson CJ; Schneider GM; Lysle DT
    Brain Behav Immun; 2000 Sep; 14(3):170-84. PubMed ID: 10970678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental evidence for immunomodulatory effects of opioids.
    Sacerdote P; Limiroli E; Gaspani L
    Adv Exp Med Biol; 2003; 521():106-16. PubMed ID: 12617569
    [No Abstract]   [Full Text] [Related]  

  • 49. Opiates and immune function. Consequences on infectious diseases with special reference to AIDS.
    Rouveix B
    Therapie; 1992 Nov; 47(6):503-12. PubMed ID: 1301643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody response and allogeneic mixed lymphocyte reaction in mu-, delta-, and kappa-opioid receptor knockout mice.
    Gaveriaux-Ruff C; Simonin F; Filliol D; Kieffer B
    J Neuroimmunol; 2004 Feb; 147(1-2):121-2. PubMed ID: 14741441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of opioid peptides on immunomodulation].
    Cheĭdo MA; Idova GV
    Ross Fiziol Zh Im I M Sechenova; 1998 Apr; 84(4):385-90. PubMed ID: 9742618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists.
    Morgan EL
    J Neuroimmunol; 1996 Mar; 65(1):21-30. PubMed ID: 8642060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence.
    Law PY; Loh HH; Wei LN
    Neuropharmacology; 2004; 47 Suppl 1():300-11. PubMed ID: 15464146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of murine macrophage cytokine production after in vivo morphine treatment.
    Franchi S; Castelli M; Moretti S; Panerai A; Sacerdote P
    Methods Mol Biol; 2015; 1230():253-61. PubMed ID: 25293332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a polyclonal antibody to the mu opioid receptor.
    Maneckjee R; Archer S; Zukin RS
    J Neuroimmunol; 1988 Feb; 17(3):199-208. PubMed ID: 2828423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.
    Shahbazian A; Heinemann A; Schmidhammer H; Beubler E; Holzer-Petsche U; Holzer P
    Br J Pharmacol; 2002 Feb; 135(3):741-50. PubMed ID: 11834622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid peptides and opioid receptors in cells of the immune system.
    Sibinga NE; Goldstein A
    Annu Rev Immunol; 1988; 6():219-49. PubMed ID: 2838048
    [No Abstract]   [Full Text] [Related]  

  • 59. Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction.
    Jacobsen JH; Watkins LR; Hutchinson MR
    Int Rev Neurobiol; 2014; 118():129-63. PubMed ID: 25175864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
    Hatzoglou A; Bakogeorgou E; Castanas E
    Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.